About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalNorth & South Carolina
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
678
By Phase
PHASE1: 4
By Status
COMPLETED: 4RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06429930Lead Sponsor
Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults
PHASE1Recruiting
56 participants
Started: Apr 11, 2025 · Completed: Dec 31, 2025
NCT05938946Lead Sponsor
Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults
PHASE1Completed
64 participants
Started: Aug 30, 2023 · Completed: Sep 2, 2024
NCT04514302Collaborator
Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19
PHASE1Completed
32 participants
Started: Dec 7, 2021 · Completed: Aug 1, 2022
NCT03326492Collaborator
Evaluation of Anti-venoms Serum in Africa
N/ACompleted
474 participants
Started: Oct 17, 2019 · Completed: Sep 14, 2021
NCT04041648Lead Sponsor
Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606
PHASE1Completed
52 participants
Started: Nov 9, 2018 · Completed: May 12, 2020
Locations (1)
Headquarters
Morrisville, NC, United States
Map
Loading map...